# OnCo record nct04644289 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04644289/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04644289", "NCT04644289" ;
  schema:name "WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC"@en ;
  schema:description "A phase 2 trial of Olaparib, Durvalumab in ovarian cancer, run by AGO Research GmbH, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04644289/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04644289> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2022-05-05" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/parp-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/durvalumab/> ;
  onco:companies <https://onco.cc/companies/ago-study-group/> .